Symptom Tracking May Aid Endometriosis Care, but Evidence Is Limited

Symptom-reporting tools (SRTs) such as period-tracking apps may help people with suspected or diagnosed endometriosis recognize symptom patterns and communicate more effectively with primary care clinicians, but evidence that the tools lead to faster diagnosis remains thin, according to a realist synthesis published in BMJ Open.¹

“SRTs appear most useful for women who actively seek them out, use them consistently, and feel confident sharing their records with health care professionals,” wrote the researchers of the study. “When professionals are receptive and value the information, SRTs can help structure appointments and improve communication.”

Endometriosis affects an estimated 10% of reproductive-age women worldwide, or about 190 million people. Because its symptoms are broad and variable, diagnosis can take between 4 and 12 years on average, and a careful menstrual history covering pain, bleeding, and associated symptoms can aid diagnosis, according to the WHO.²

Researchers at Bangor University and Cardiff University in the UK searched 8 databases between January and April 2024, with an update in October 2025, to examine how, and for whom, SRTs work in primary care.¹ Of 102 included studies, 83 informed initial theory development, and 19 were used to refine those theories. The 19 synthesis studies involved 22,266 participants aged 13 to 70 years, and 15 were cross-sectional. Tools examined included the generic period trackers Flo and Clue, the menstrual pain–specific Period ImPact and Pain Assessment (PIPPA), and the endometriosis-specific Raising Awareness Tool for Endometriosis (RATE) and Phendo.

Independent Tracking Built Awareness but Could Add Stress

Used on their own, SRTs appeared to help women better understand their symptoms and triggers and know when to seek care. In 1 survey of generic tracker users, 90% said tracking helped them understand their bodies and cycles, and 72% reported greater perceived control over their health. In a study of PIPPA, 48% of users reconsidered what constituted a normal period, and use of self-management strategies rose from 65% to 86%.

Tracking had drawbacks: some women felt stressed when their periods deviated from app predictions or when they forgot to log data, and for others, it was a constant reminder of illness that deepened hopelessness. Still, 64% of Clue users in 1 survey said they would feel more health-related stress without tracking. Many tools also lacked a way to record emotional symptoms, even though more than 70% of Clue users in that survey listed them among their main symptoms of concern.

Tracker Data Helped GPs Structure Visits and Guide Referrals

Within consultations, SRT data helped women describe symptoms using correct terminology and gave general practitioners (GPs) objective evidence to structure appointments and ask more relevant questions. In the PIPPA study, 56% of women who used the tool during GP appointments were referred to gynecology, and RATE use prompted further investigations regardless of diagnosis.

Barriers included short appointments, inconsistent data formats across apps, and the high health literacy some tools demand. Some gynecology clinicians worried that tracking could heighten patients' focus on their symptoms, and women often felt dismissed when clinicians did not engage with their data. Without guidance, the authors wrote, SRT use could cause distress and disempowerment.

Mostly Cross-Sectional Evidence Limits Firm Conclusions

Because most included studies were cross-sectional, the findings reflect perceived rather than demonstrated causal chains, the authors noted, and the review was limited to English-language sources from high-income countries. The analysis reflected the UK's GP-first referral system, though many included studies came from countries allowing direct specialist access. Cardiff University owns the intellectual property for the free Endometriosis Cymru Symptom Tracking and Reporting Tool, which some authors helped develop.

SRTs appear most useful for patients who use them consistently and feel confident sharing their records and for clinicians who are receptive to the data. The authors recommended standardizing how tracker data are presented, embedding evidence-based tools in endometriosis guidelines, protecting user privacy, and ensuring SRTs complement rather than replace clinical investigation. They called for longitudinal and prospective research to determine whether the tools shorten time to diagnosis or improve shared decision-making.

References

1. Silveira Bianchim M, Joseph R, Boivin J, Noyes J. Use of symptom-reporting tools to support endometriosis identification and management in primary care: a realist synthesis. BMJ Open. 2026;16(9):e114764. doi:10.1136/bmjopen-2025-114764.
2. Endometriosis. WHO. October 15, 2025. Accessed September 29, 2026. https://www.who.int/news-room/fact-sheets/detail/endometriosis